Read + Share
Amedeo Smart
Independent Medical Education
Schultheiss JPD, Mahmoud R, Fidder HH, Oldenburg B, et al. Editorial: risk of loss of response to anti TNFalpha in patients with inflammatory bowel diseases - the longer the less? Authors' reply. Aliment Pharmacol Ther 2022;55:246.PMID: 34970765
Email
LinkedIn
Facebook
Twitter
Privacy Policy